# Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever

> **NCT04187755** · PHASE4 · COMPLETED · sponsor: **Indonesia University** · enrollment: 72 (actual)

## Conditions studied

- Neutropenia, Febrile
- Leukemia
- Pediatric Cancer
- Antibiotic Reaction

## Interventions

- **DRUG:** Ceftazidime Injection
- **DRUG:** Cefepime Injection

## Key facts

- **NCT ID:** NCT04187755
- **Lead sponsor:** Indonesia University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-01
- **Primary completion:** 2019-07-31
- **Final completion:** 2019-07-31
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2019-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04187755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04187755, "Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04187755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*